Page 32 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19 March 10, 2021 GMT VANCOUVER, British Columbia--(BUSINESS WIRE)--Mar 10, 2021-- AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), and etesevimab ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results InspireMD Inc.March 9, 2021 GMT TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the fourth q...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate VALNEVAMarch 8, 2021 GMT The Phase 2 study will include both adult and pediatric subjects with an aim to support acceleration of the vaccine candidate’s pediatric program   VLA15 will be  tested at two different schedules (Month 0-2-6 or Month 0-6) receiving the selected dose of 180µg VLA15 is the only Lyme...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento ... Sorrento Therapeutics, Inc.March 8, 2021 GMT Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharm. China’s National Medical Products Administration (“NMPA”) clears Lee’s Pharm to conduct a Phase III, multicenter, randomized, double blinded,...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for ... Cara Therapeutics, Inc.March 8, 2021 GMT FDA has set Prescription Drug User Fee Act (PDUFA) target action date of August 23, 2021 If approved, KORSUVA™ injection would be first therapy for treatment of pruritus in hemodialysis patients STAMFORD, Conn, and ST. GALLEN, Switzerland, March 08, 2021 (GLOBE...

Press release content from Business Wire. The AP news staff was not involved in its creation. Masimo Monitoring Solutions Promote Newborn and Maternal Safety March 8, 2021 GMT Masimo Newborn Sensor (Photo: Masimo) NEUCHATEL, Switzerland--(BUSINESS WIRE)--Mar 8, 2021-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to meas...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Yanimed Achieves ASTM Medical Standards, Looks to Expand Footprint in the US Blokkx LtdMarch 8, 2021 GMT Yanimed has recently achieved the ASTM D6319-19 standards and submitted the 510k application. These developments are critical to the brand’s ambitious expansion plans in the US. NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Yanimed is pleased to announce that it has recently achieved the medical d...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.